Headquartered in Thousand Oaks, California, Amgen is a pioneering biotechnology company founded in 1980, whose core expertise in recombinant protein engineering has been applied to create MariTide: a multispecific molecule that simultaneously activates the GLP-1 receptor (driving weight loss) and antagonises the GIP receptor the opposite mechanism to tirzepatide conjugated to an Fc region for extended half-life enabling monthly or less frequent dosing
Compare with similar compounds The three compounds in the GLP-1-class spectrum (Semaglutide, Tirzepatide, Retatrutide) represent successive expansions of receptor coverage from one to two to three receptors
Given the significant liability involved, obtaining thorough and appropriate medical clearance is essential
Lean mass dropped by around 9.7%, but fat mass fell by 19.3%, and the proportion of lean mass in the body increased by about 3 percentage points
Yessemaglutide is working even if weight loss feels slower than anticipated
Read next Which GLP-1 medication is most effective for weight loss
